Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        Zamaporvint by Redx Pharma for Metastatic Colorectal Cancer: Likelihood of Approval
Zamaporvint is under clinical development by Redx Pharma and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...
                                                Data Insights
                                                
                                        Zamaporvint by Redx Pharma for Extrahepatic Bile Duct Cancer: Likelihood of Approval
Zamaporvint is under clinical development by Redx Pharma and currently in Phase II for Extrahepatic Bile Duct Cancer. According to...
